HomeSWTX • NASDAQ
add
SpringWorks Therapeutics Inc
Previous close
$33.00
Day range
$32.61 - $33.89
Year range
$18.00 - $53.90
Market cap
2.46B USD
Avg Volume
868.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 59.73M | — |
Operating expense | 102.20M | 23.35% |
Net income | -39.92M | 48.77% |
Net profit margin | -66.83 | — |
Earnings per share | -0.54 | 56.80% |
EBITDA | -44.08M | 46.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 383.88M | -19.47% |
Total assets | 617.33M | 19.33% |
Total liabilities | 60.60M | -8.02% |
Total equity | 556.73M | — |
Shares outstanding | 74.24M | — |
Price to book | 4.40 | — |
Return on assets | -17.63% | — |
Return on capital | -19.74% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -39.92M | 48.77% |
Cash from operations | -41.79M | 12.59% |
Cash from investing | 289.00K | -99.52% |
Cash from financing | 3.37M | 1,085.67% |
Net change in cash | -38.13M | -402.55% |
Free cash flow | -39.83M | -56.44% |
About
Founded
2017
Headquarters
Website
Employees
305
